Question-and-Answer Session
Operator
(Operator Instructions). And your first question comes from the line of Jeff Goater with Cowen & Company.
Jeff Goater – Cowen & Company
Hi, good morning, thanks for taking my question. Ben, I know, you’re not providing financial guidance but can you give us a sense of where the cuts were made?
Benjamin L. Palleiko
So far, we beside the headcount reductions we have made some cuts in our capital expenditures and a fair bit of the market research efforts we have done in conjunction with clinical candidates clearly since we did the budget some of the timelines and projects have shifted a little bit. So, some of the expenses come from there, we have also done an initial scrub on program spending and eliminated any type of activities that weren’t going to effect the timelines on moving those projects forward. And then, as a whole bunch more general G&A overhead reductions you can make, travel expenses and such. So, they add up to a reasonably good amount of money here on the first pass and we’re going back again now to dig in some more.
Jeff Goater – Cowen & Company
And I was just wondering is there any update on the declaratory judgment motion that was filed in the Impax case and if not, do you have sense of timing here?
Benjamin L. Palleiko
So, we actually dismissed those claims when Impax came back with the second filing.
Jeff Goater – Cowen & Company
Okay.
Benjamin L. Palleiko
And there was a sort of convoluted legal rationale to that. But essentially it was overtaken by events when they came back and certified again.
Jeff Goater – Cowen & Company
Okay.
Benjamin L. Palleiko
And so the first lawsuit sits out there as purely a patent infringement suit at this point, and then the second lawsuit has been filed as well and looks very similar now to first.
Jeff Goater – Cowen & Company
Okay. And then, finally I guess from our contractual standpoint how does that all, would a change of control at Endo effect your Opana ER agreement?
Jennifer L. Good
There is no contractual change at all.
Jeff Goater – Cowen & Company
Okay, thanks.
Operator
And your next question comes from the line of Larry Neibor, Robert W. Baird
Lawrence H. Neibor – Robert W. Baird & Co.
Good morning.
Jennifer L. Good
Good morning, Larry.
- To read the full transcript on Seeking Alpha, click here »
